Status: current, Defined. Date: 28-Feb 2019. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3224231000168111 | Contrave 8/90 (bupropion hydrochloride 90 mg + naltrexone hydrochloride 8 mg) modified release tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3224241000168119 | Contrave 8/90 modified release tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Contrave 8/90 (bupropion hydrochloride 90 mg + naltrexone hydrochloride 8 mg) modified release tablet, 112 tablets (trade product pack) | has TPUU | True | Contrave 8/90 modified release tablet | Inferred relationship | Some | 1 |
Contrave 8/90 (bupropion hydrochloride 90 mg + naltrexone hydrochloride 8 mg) modified release tablet, 112 tablets, blister pack (containered trade product pack) | has TPUU | True | Contrave 8/90 modified release tablet | Inferred relationship | Some | 1 |
Contrave 8/90 modified release tablet, 28, blister pack | has TPUU | True | Contrave 8/90 modified release tablet | Inferred relationship | Some | 955195206 |
Contrave 8/90 modified release tablet, 28 | has TPUU | True | Contrave 8/90 modified release tablet | Inferred relationship | Some | 1182730462 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set